Dr. Amy Liao Receives the Wallace A. Coulter Award for Healthcare Innovation
Brooks Automation (Nasdaq: BRKS) announced that Dr. Amy Liao, president of Brooks Life Science Services, has received the prestigious Wallace A. Coulter award for healthcare innovation on October 16, 2020. This award honors individuals for their lifetime contributions to patient healthcare. Dr. Liao, recognized for her over 20 years in genomics, will address the 2020 Biomedical Engineering Society's virtual meeting. Under her leadership, Brooks' GENEWIZ division has become a key player in genomic services, enhancing the company’s reputation and innovation in healthcare.
- Dr. Amy Liao received the Wallace A. Coulter award, highlighting her contributions to healthcare and enhancing the company's credibility.
- Recognition of Dr. Liao's achievements could positively influence investor confidence and the company's market position.
- None.
CHELMSFORD, Mass., Oct. 16, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) announced today that Dr. Amy Liao, president of Brooks Life Science Services, has received the Biomedical Engineering Society's Wallace A. Coulter award for innovation in healthcare. The Coulter award recognizes an outstanding individual who has demonstrated a lifetime commitment to and made important contributions to patient healthcare. Dr. Liao will be speaking at the plenary session of the 2020 Biomedical Engineering Society's virtual meeting on Friday October 16, 2020.
"We are very proud to see Amy recognized by the Biomedical Engineering Society with this award," commented Steve Schwartz, CEO and president of Brooks Automation. "Amy's accomplishments with over 20 years in the field of genomics has led to breakthrough innovations in gene sequencing and gene synthesis, and in GENEWIZ, she built a company that has supported thousands of customers in their pursuit of scientific discoveries. All of us at Brooks congratulate Amy for this recognition of her achievements."
Dr. Amy Liao was appointed President of Brooks Life Sciences Services in April 2020. She joined Brooks in November 2018 following its acquisition of GENEWIZ, a global provider of genomics services, which she co-founded in 1999. Dr. Liao held various leadership positions during her tenure at GENEWIZ culminating in her appointment as Chief Executive Officer in January 2017. Dr. Liao received her Ph.D. in Biochemistry and Cell Biology from SUNY Stony Brook. She did her post doctorate studies at Columbia University before leaving to found GENEWIZ. She holds a B.S. in Biochemistry from Nankai University, China and an M.S. in Biochemistry from Tsinghua University, China.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.
INVESTOR and MEDIA CONTACT:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-amy-liao-receives-the-wallace-a-coulter-award-for-healthcare-innovation-301153908.html
SOURCE Brooks Automation
